1 års afkast (CAGR)
-34.11%
Acarix A/S Exchange (ST, SEK)
ACARIX.ST
0.19
+0.00 (+0.31%)
HealthcareMedical Devices
Loading...
3 års afkast (CAGR)
-4.00%
5 års afkast (CAGR)
-27.47%
10 års afkast (CAGR)
-
Adobe 2026 Q3 – Er det stemningen, der driver prisen?
Læs mereMarkedsværdi
238.67M
Pris/omsætning
25.88
Ent værdi
213.75M
Pris/bog
5.45
Udbytte afkast
0.00%
Vekst år
-
Udbyttevækst
-
FCF-udbetaling
0.00%
Efterfølgende P/E
-
PEG
-
Fremtidig P/E
-
EPS-vekst
-36.85%
Oplysninger om aktier
Hvad er en børs? Drift, aktører, eksempler
Læs mereAktiediagram
Loading...
Aktiekurs-data
| Åbning | 0.19 |
| Daglig høj | 0.19 |
| Daglig lav | 0.19 |
| Daglig volumen | 1.06M |
| Højeste gennem alle tider | 8.29 |
| 1 års analytiker estimat | 0.40 |
| Beta | -0.21 |
| EPS (TTM) | -0.03 |
| Udbytte pr. aktie | 0.00 |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | - |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ACARIX.ST | S&P500 | |
| Nuværende prisfald fra top notering | -97.68% | -0.77% |
| Højeste prisfald | -97.86% | -56.47% |
| Højeste efterår dato | 21 Dec 2023 | 9 Mar 2009 |
| Gennemsnitlig fald fra toppen | -82.17% | -10.65% |
| Gennemsnitlig tid til nyt højdepunkt | 413 days | 12 days |
| Maks. tid til nyt højdepunkt | 2472 days | 1805 days |
Nyheder
Acarix AB (ACIXF) reports robust Q2 2026 results with US revenue up 223%, UAE market entry, and key progress toward CPT1 reimbursement transition.
16. august 2026
Acarix has secured regulatory approval for its CADScor system in the UAE, a step that paves the way for the device's commercial availability.
11. august 2026
Acarix AB (publ) today announced the publication of a peer-reviewed study in PLOS Digital Health showing that the seismocardiography (SCG) technology at the heart of its CE-marked, FDA-cleared CADScor...
11. september 2026
As European markets navigate the complexities of geopolitical tensions and inflationary pressures, investors are increasingly exploring diverse opportunities across various sectors. Penny stocks, a te...
21. maj 2026
Acarix AB (publ) today announced that the CADScor® System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP), clearing the wa...
10. august 2026
European markets have experienced volatility recently, with the pan-European STOXX Europe 600 Index reaching a new high but ending the week nearly flat. As investors navigate these fluctuations, penny...
17. februar 2026
Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745).
4. februar 2026
As December 2025 unfolds, the European markets are showing a mix of cautious optimism and strategic anticipation, with the pan-European STOXX Europe 600 Index posting modest gains amid hopes for inter...
12. december 2025
As the European market navigates a mixed landscape with major stock indexes showing varied performance, investors are keeping a close eye on opportunities that may arise from current economic conditio...
4. november 2025